This site uses cookies to improve your experience and to provide services and advertising. By continuing to browse, you agree to the use of cookies described in our Cookies Policy. You may change your settings at any time but this may impact on the functionality of the site. To learn more see our Cookies Policy.
#Open journalism No news is bad news

Your contributions will help us continue to deliver the stories that are important to you

Support The Journal
Dublin: 7 °C Tuesday 2 June, 2020

Emerade adrenaline pen recalled by health regulator

Anyone who uses the pens are being told to return them to pharmacies.

Image: Shutterstock/Lestertair

A BATCH OF adrenaline pens used to treat allergic reactions is being recalled. 

The recall of the Emerade pens was announced today by the Health Products Regulatory Authority (HPRA).

The decision to recall a batch of the pens was made after some Emerade pens in other countries failed to produce an injection and failed to activate, with the potential for a blocked needle.

The pen is an emergency treatment for anaphylaxis. 

The recall covers batches of: 

  • 150mcg pre-filled Emerade pens
  • 300mcg pre-filled Emerade pens
  • 500mcg pre-filled Emerade pens

Anyone who has an Emerade pen has been told by HPRA to return it to their local pharmacy and get it replaced with an alternative product. 

The cause of the activation failure is unknown, as is rate of the defect in the pen.

  • Share on Facebook
  • Email this article

About the author:

Read next:


This is YOUR comments community. Stay civil, stay constructive, stay on topic. Please familiarise yourself with our comments policy here before taking part.
write a comment

    Leave a commentcancel